GE HEALTHCARE TECHNOLOGIES INC. Operating Cash Flow
GE HEALTHCARE TECHNOLOGIES INC. (GEHC) reported Operating Cash Flow of $290.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-04-29
- GE HEALTHCARE TECHNOLOGIES INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $290.00M, a 16.00% increase year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. net cash provided by (used in) operating activities for the quarter ending 2025-06-30 was $94.00M.
- GE HEALTHCARE TECHNOLOGIES INC. net cash provided by (used in) operating activities for the quarter ending 2025-03-31 was $250.00M, a 40.33% decline year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. net cash provided by (used in) operating activities for the quarter ending 2024-06-30 was -$119.00M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month |
|---|---|---|---|
| 2026-03-31 | $290.00M 10-Q · filed 2026-04-29 | ||
| 2025-06-30 | $94.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $344.00M 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $250.00M 10-Q · filed 2026-04-29 | ||
| 2024-06-30 | -$119.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $300.00M 10-Q · filed 2025-07-30 | |
| 2024-03-31 | $419.00M 10-Q · filed 2025-04-30 | ||
| 2023-09-30 | $650.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $583.00M derived: sum of 2 quarters · filed 2024-07-31 | $1.05B 10-Q · filed 2023-10-31 |
| 2023-06-30 | -$67.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $401.00M 10-Q · filed 2024-07-31 | |
| 2023-03-31 | $468.00M 10-Q · filed 2024-04-30 | ||
| 2022-09-30 | $622.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $603.00M derived: sum of 2 quarters · filed 2023-10-31 | $1.07B 10-Q · filed 2023-10-31 |
| 2022-06-30 | -$19.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-25 | $449.00M 10-Q · filed 2023-07-25 | |
| 2022-03-31 | $468.00M 10-Q · filed 2023-04-25 |